Safia Abdillahi
Nurse Practitioner · Washington, DCNPI 1881788966
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,975 of the $10,762 with a category attached, or 74.1%. 21 manufacturers reported payments, led by Amneal Pharmaceuticals LLC at 25.7% of the total. Among nurse practitioner clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 359 payments — averaging $29.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$3K
- AbbVie$2K
- Acadia Pharmaceuticals Inc$1K
- MDD US Operations, LLC$798
- Neurocrine Biosciences, Inc.$678
- Kyowa Kirin, Inc.$588
- plus $2K from 15 others
What the payments were for
- Consulting fees$2,76326%
- Food & beverage$7,97574%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 45 | $2,769 |
| AbbVie(2 entities) | 118 | $2,334 |
| Acadia Pharmaceuticals Inc | 22 | $1,241 |
| MDD US Operations, LLC | 28 | $798 |
| Neurocrine Biosciences, Inc. | 26 | $678 |
| Kyowa Kirin, Inc. | 12 | $588 |
| Sunovion Pharmaceuticals Inc. | 33 | $514 |
| Teva Pharmaceuticals USA, Inc. | 20 | $478 |
| Supernus Pharmaceuticals, Inc. | 7 | $328 |
| Merz Pharmaceuticals, LLC | 13 | $298 |
| Avanir Pharmaceuticals, Inc. | 9 | $177 |
| Abbott | 7 | $135 |
| GE HealthCare | 4 | $79 |
| Eisai Inc. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Medtronic | 1 | $59 |
| Acorda Therapeutics, Inc | 3 | $58 |
| Corium, LLC | 1 | $28 |
| UCB, Inc. | 1 | $25 |
| Avion Pharmaceuticals | 1 | $19 |
| Biogen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,762 in reported general payments places this provider in the 95th percentile of 224 nurse practitioner providers in District of Columbia.
See all nurse practitioner providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GocovriAmantadine Hcl | 31 | $145,850 |
| RytaryCarbidopa/Levodopa | 79 | $88,403 |
| NuplazidPimavanserin Tartrate | 11 | $54,729 |
| OngentysOpicapone | 19 | $20,247 |
| NeuproRotigotine | 23 | $18,008 |
| Rasagiline Mesylate | 46 | $9,860 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 208 | $7,271 |
| Pramipexole ErPramipexole Di-Hcl | 22 | $6,844 |
| Entacapone | 15 | $2,472 |
| Galantamine ErGalantamine Hbr | 14 | $2,414 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 24 | $1,577 |
| Donepezil Hcl | 65 | $948 |
| AmantadineAmantadine Hcl | 12 | $909 |
| Memantine Hcl | 32 | $672 |
| Primidone | 15 | $479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MDD US Operations, LLCGocovri | $798 | $145,85031 claims |
| Amneal Pharmaceuticals LLCRytary | $2,769 | $88,40379 claims |
| Acadia Pharmaceuticals IncNuplazid | $1,241 | $54,72911 claims |
| Neurocrine Biosciences, Inc.Ongentys | $678 | $20,24719 claims |
| UCB, Inc.Neupro | $25 | $18,00823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 224 nurse practitioner providers in District of Columbia.
Other nurse practitioner in Washington
- Rasheda PersingerWashington$88K
- Caitlin YazelWashington$45K
- Aimee LestrangeWashington$37K
- Guinevere QueWashington$27K
- Cynthia BitherWashington$17K
- Brigid ReynoldsWashington$6K
- Odette NtamWashington$5K
- Kathryn HilgartnerWashington$5K
- Mary AlderWashington$4K
- Joseph HugginsWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.